Bulletin
Investor Alert

New York Markets Close in:

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

Market open

 --Real time quotes

Dec 1, 2021, 1:27 p.m.

/zigman2/quotes/205619834/composite

$

323.43

Change

-29.00 -8.23%

Volume

Volume 14.00m

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 352.43

$ 323.43

Change

-29.00 -8.23%

Day low

Day high

$312.72

$336.36

Open

52 week low

52 week high

$102.66

$497.49

Open

Insider Actions for Moderna Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/22/2021 Juan Andres
See remarks
15,000   Disposition at $268.18 per share. 4,022,700
11/22/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/22/2021 Juan Andres
See remarks
10,000   Derivative/Non-derivative trans. at $14.22 per share. 142,200
11/19/2021 Juan Andres
See remarks
5,000   Disposition at $265.71 per share. 1,328,550
11/19/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/18/2021 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $245.89 per share. 2,458,900
11/17/2021 Stéphane Bancel
Chief Executive Officer; Director
4,000   Gift at $0 per share. 0
11/17/2021 Stéphane Bancel
Chief Executive Officer; Director
9,000   Disposition at $234.57 per share. 2,111,130
11/17/2021 Juan Andres
See remarks
5,000   Disposition at $234.57 per share. 1,172,850
11/17/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/15/2021 Stephen Hoge
President
15,000   Disposition at $231.01 per share. 3,465,150
11/15/2021 Juan Andres
See remarks
5,000   Disposition at $231.01 per share. 1,155,050
11/15/2021 Stephen Hoge
President
10,000   Derivative/Non-derivative trans. at $0.99 per share. 9,900
11/15/2021 Stephen Hoge
President
5,000   Derivative/Non-derivative trans. at $10.9 per share. 54,500
11/15/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/12/2021 Stephen Hoge
President
5,000   Disposition at $225.86 per share. 1,129,300
11/12/2021 Juan Andres
See remarks
5,000   Disposition at $225.86 per share. 1,129,300
11/12/2021 Stephen Hoge
President
5,000   Derivative/Non-derivative trans. at $10.9 per share. 54,500
11/12/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/11/2021 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $227.67 per share. 2,276,700
11/10/2021 Stéphane Bancel
Chief Executive Officer; Director
30,000   Gift at $0 per share. 0
11/10/2021 Stéphane Bancel
Chief Executive Officer; Director
4,000   Gift at $0 per share. 0
11/10/2021 Stéphane Bancel
Chief Executive Officer; Director
9,000   Disposition at $230 per share. 2,070,000
11/10/2021 Juan Andres
See remarks
5,000   Disposition at $230 per share. 1,150,000
11/10/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/08/2021 Juan Andres
See remarks
15,000   Disposition at $233.13 per share. 3,496,950
11/08/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050
11/08/2021 Juan Andres
See remarks
10,000   Derivative/Non-derivative trans. at $14.22 per share. 142,200
11/05/2021 Juan Andres
See remarks
5,000   Disposition at $240 per share. 1,200,000
11/05/2021 Juan Andres
See remarks
5,000   Derivative/Non-derivative trans. at $12.21 per share. 61,050

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
63 Purchases
116 Sales
395,000
690,250
Last 6 months
130 Purchases
261 Sales
810,000
1,455,950
Last 12 months
265 Purchases
895 Sales
1,635,014
13,525,643

Officers and Executives

Mr. Stéphane Bancel
Chief Executive Officer & Director
Dr. Stephen Hoge
President
Mr. David W. Meline
Chief Financial Officer
Dr. Paul Burton
Chief Medical Officer
Mr. Juan Andres
Chief Technical Operations & Quality Officer
Dr. Melanie Ivarsson
Chief Development Officer
Ms. Jacqueline Miller
Senior VP-Infectious Disease Development
Mr. Patrick Norman Bergstedt
SVP-Commercial Vaccines
Mr. Raymond C. Jordan
Chief Corporate Affairs Officer
Mr. John Lepore
Senior Vice President-Government Engagement
Dr. José M. Vega
Chief Safety Officer
Dr. Corinne Le Goff
Chief Commercial Officer
Ms. Kate Cronin
Chief Brand Officer
Mr. Marcello Damiani
Chief Digital & Operational Excellence Officer
Ms. Jennifer Ling Lee
Chief Accounting Officer
Ms. Tracey Franklin
Chief Human Resources Officer
Dr. Shannon Thyme Klinger
Secretary & Chief Legal Officer
Dr. Charbel Haber
Senior Vice President-Regulatory Affairs
Dr. Noubar B. Afeyan
Chairman
Dr. Francois Nader
Independent Non-Executive Director
Dr. Sandra J. Horning
Independent Director
Ms. Elizabeth E. Tallett
Independent Director
Dr. Elizabeth G. Nabel
Independent Director
Mr. Paul L. Sagan
Independent Non-Executive Director
Dr. Robert S. Langer
Independent Non-Executive Director
Mr. Stephen A. Berenson
Independent Non-Executive Director
Link to MarketWatch's Slice.